Table 1.
Functional categories | Rx-1D | Rx-3D | Rx-5D | Rx-7D | Rx-14D | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Effective treatment | Ineffective treatment | Effective treatment | Ineffective treatment | Effective treatment | Ineffective treatment | Effective treatment | Ineffective treatment | Effective treatment | Ineffective treatment | |||||||||||
N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | |
Cell wall and cell wall process | 40 | 6 | 20 | 3 | 125 | 18 | 14 | 2 | 250 | 36 | 5 | 1 | 52 | 8 | 4 | 1 | 22 | 3 | 4 | 1 |
Conserved hypotheticals | 76 | 7 | 26 | 3 | 126 | 12 | 20 | 2 | 400 | 39 | 5 | 0 | 48 | 5 | 4 | 0 | 30 | 3 | 2 | 0 |
Information pathways | 15 | 7 | 14 | 6 | 41 | 18 | 15 | 7 | 78 | 34 | 4 | 2 | 18 | 8 | 0 | 0 | 11 | 5 | 5 | 2 |
Insertion sequences and phages | 16 | 22 | 2 | 3 | 7 | 9 | 1 | 1 | 27 | 36 | 0 | 0 | 5 | 7 | 0 | 0 | 1 | 1 | 0 | 0 |
Intermediary metabolism and respiration | 39 | 5 | 35 | 4 | 118 | 14 | 28 | 3 | 273 | 33 | 3 | 0 | 57 | 7 | 11 | 1 | 30 | 4 | 6 | 1 |
Lipid metabolism | 10 | 4 | 19 | 8 | 48 | 21 | 14 | 6 | 30 | 13 | 7 | 3 | 25 | 11 | 2 | 1 | 18 | 8 | 2 | 1 |
Not classified | 48 | 12 | 14 | 4 | 51 | 13 | 11 | 3 | 135 | 34 | 6 | 2 | 21 | 5 | 4 | 1 | 24 | 6 | 6 | 2 |
PE/PPE | 12 | 8 | 10 | 6 | 21 | 13 | 11 | 7 | 72 | 46 | 0 | 0 | 16 | 10 | 3 | 2 | 8 | 5 | 1 | 1 |
Regulatory proteins | 14 | 8 | 7 | 4 | 30 | 17 | 2 | 1 | 74 | 42 | 0 | 0 | 12 | 7 | 0 | 0 | 4 | 2 | 1 | 1 |
Virulence detoxification adaptation | 14 | 14 | 4 | 4 | 22 | 22 | 4 | 4 | 38 | 38 | 0 | 0 | 12 | 12 | 0 | 0 | 8 | 8 | 1 | 1 |
N -Detected genes in each category, % percentage; numbers in bold represent the percentage of dysregulated gene calculated based on the number of genes in the particular functional category, numbers in italics indicate the significantly dysregulated functional categories. Rx-1d–Rx-14d – Days post-treatment initiation.